Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence

P Butow, S Kelly, Belinda Thewes, George Hruby, L Sharpe, Jane Beith

Research output: Contribution to journalArticlepeer-review

61 Citations (Scopus)

Abstract

Background: Fear of cancer recurrence (FCR) is a common and severe problem amongst cancer survivors, but mechanisms to explain its development and maintenance are still lacking. The self-regulatory executive function (S-REF) model suggests that metacognitions and attentional bias to cancer-related words may explain high FCR. Thus, this study aimed to explore relationships between FCR, metacognitions and attentional bias in a mixed group of cancer survivors.

Method: Sixty-three early-stage breast or prostate cancer survivors, diagnosed within 6 months to 5 years prior to participation and who had completed all hospital-based treatment with no evidence of cancer recurrence were recruited through two metropolitan oncology clinics. Participants completed
a questionnaire battery and the dot-probe task.

Results:
Survivors with clinical FCR had significantly greater positive beliefs about worry (10.1 vs 7.4, p = 0.002) and beliefs about the uncontrollability and danger of worry (12.0 vs 7.7, p = 0.000) than those with non-clinical FCR, whereas the total metacognition score significantly predicted FCR in
multiple regression analysis (β = 0.371, p = 0.001). No significant differences were detected between participants scoring above and below clinical FCR levels in attention bias indices.

Conclusions: This study found partial support for the S-REF model of FCR, with metacognitions but not attentional bias found to be related to FCR. Further research is needed to explore attentional biases in more detail.
Original languageEnglish
Pages (from-to)416-423
Number of pages8
JournalPsycho-Oncology
Volume24
Issue number4
Early online date25 Aug 2014
DOIs
Publication statusPublished - 2015

Fingerprint

Dive into the research topics of 'Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence'. Together they form a unique fingerprint.

Cite this